Generic drugs undergo clinical testing for side effects
the verdict
SUPPORTED
the evidence backs this
confidence 75/100
Generic drugs undergo rigorous bioequivalence and clinical testing that routinely include monitoring for side effects and adverse events.
Evidence for · 5
Bioequivalence of a Fixed-Dose Combination of Relugolix, Estradiol, and Norethindrone Acetate: An Open-Label, Randomized, Fully Replicate Crossover Study in Healthy Postmenopausal Women Under Fasting Conditions.
2026 · cited by 0
Evaluates generic relugolix/estradiol/norethindrone acetate and monitors adverse events during bioequivalence testing.
See more details
More for · 4
Comparative bioequivalence of 1 mg and 4 mg tacrolimus extended-release tablets: randomized, open label, fully replicate, crossover trials in healthy adult subjects.
2026 · cited by 0
Assesses safety, tolerability, and adverse events for generic tacrolimus extended-release tablets.
Pharmacokinetics and Bioequivalence Evaluation of Piracetam Tablet: A Randomized, Single-Dose, Two-Period, Crossover Study in Healthy Chinese Participants Under Fasting and Fed Conditions.
2026 · cited by 0
Monitors adverse events and tolerability for a generic piracetam tablet compared to a reference product.
Bioequivalence evaluation of two cariprazine hard capsule formulations.
2026 · cited by 0
Assesses the safety profile and adverse events of a generic cariprazine formulation.
Bioequivalence assessment between two formulations of a film-coated fixed-dose combination of metformin and vildagliptin (850/50mg) in healthy Tunisian subjects under fed conditions.
2026 · cited by 0
Monitors adverse events during bioequivalence and clinical testing of a generic metformin/vildagliptin combination.